Myopia Progression clinical trials

Explore recruiting myopia progression clinical trials.

Recruiting myopia progression studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Myopia Progression trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomized, double-blind, placebo-controlled dose-finding study of 0.05%, 0.025%, 0.01% and 0.005% atropine eye drops to inhibit myopia progression in children in a European population

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Brimonidine eye drops in the prevention of myopia progression

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Safety and efficacy of T10430 eye drops in controlling paediatric myopia progression

Ireland

Therapeutic exploratory (Phase II) EU CTIS Study details

Investigator led, double-masked, multicentre, randomized clinical trial for the comparison of atropine 0.5% versus atropine 0.05% eye drops for the prevention of myopia progression in Dutch children

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

A phase III, randomized, double blind, multiple doses, placebo-controlled parallel-group, adaptive study to evaluate the efficacy of atropine to treat the progression of myopia in children and adolescents from 3 to less than 18 years of age (MODERATO Study)

Poland, Italy, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Postmarketing Parallel Randomized Clinical Trial to Determine the Efficacy and Safety of Atropine and DIMS Lenses in the Control of Myopia in a Pediatric Population

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Myopia Progression trials by city

Myopia Progression in Toronto Myopia Progression in Vancouver Myopia Progression in Montreal Myopia Progression in Calgary Myopia Progression in Edmonton Myopia Progression in Ottawa Myopia Progression in Winnipeg Myopia Progression in Quebec City Myopia Progression in Hamilton Myopia Progression in Kitchener Myopia Progression in London Myopia Progression in Halifax Myopia Progression in New York Myopia Progression in Los Angeles Myopia Progression in Chicago Myopia Progression in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease